Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC100420758 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PAX8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FGF13-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
HMGN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FTH1P5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BOK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HNRNPD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGKC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00163 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXL22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DTWD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C16orf62 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIAA1191 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITFG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPMT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHAX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on